Pressemitteilung BoxID: 151259 (Geratherm Medical AG)
  • Geratherm Medical AG
  • Fahrenheitstrasse 1
  • 98716 Geschwenda

Geratherm Medical AG opts to carry out capital increase of up to 10%

Capital increase

(lifePR) (Geschwenda, ) The Managing Board of Geratherm Medical AG (ISIN: DE0005495626) received Supervisory Board approval today to carry out a capital increase of up to 10 % of the existing capital stock from approved capital. This move excludes shareholders' subscription rights in line with sec. 5 (5) of the Articles of Association. As part of a private placement, up to 450,000 new shares with dividend rights from the fiscal year 2009 onwards will be issued in return for cash contributions. This would then increase the Company's capital stock by a possible EUR 450,000.00 from EUR 4,500,000.00 up to a potential EUR 4,950,000.00.

The new shares will be offered to qualified institutional investors both in Germany and abroad as part of an accelerated book building process. The capital increase is being supported by Close Brothers Seydler Bank AG, Frankfurt am Main as sole lead manager und sole bookrunner.

The new shares are to be released for trading in the regulated market (Prime Standard) of the Frankfurt Stock Exchange without prospectus.

Geratherm Medical AG

Geratherm Medical is an internationally operating medical products enterprise with the business areas 'Temperature Management', 'Cardio' and 'Respiratory'. Our company's roots are in temperature measurement in the medical sphere. In this business area we offer a broad spectrum of products, most of which have unique selling points. We supply our customers/patients with high-quality products ranging from thermometers to complex warming systems for use in the operating theatre and by emergency rescue services. In the Cardio business area we concentrate on the development of products for the detection of atrial fibrillation as a measure to prevent strokes. The Respiratory segment develops and markets products for the assessment of pulmonary function.

In all three business areas, Geratherm has patent-protected basic technologies at its disposal.

We regard ourselves as a research-based medical products company with a clear focus on medical diagnostic devices that generate vital data.

Geratherm shares have been listed in the Prime Standard segment of the Frankfurt Stock Exchange since the year 2000. Geratherm Medical continues to be represented in the German Entrepreneurial Index and in the German Health-Care Index.